-
Medications used to treat inflammatory bowel disease (IBD) have significantly improved patient outcomes and delayed time to surgery. However, some of these therapies are recognized to increase the general risk of infection and have an unclear impact on postoperative infection risk.Read the full review here.
October 27 2020
-
About half of patients with Crohn's disease (CD) require surgery within 10 years of diagnosis. Resection of the affected segment is highly effective, however the majority of patients experience clinical recurrence after surgery. Most of these patients have asymptomatic endoscopic recurrence weeks or months before starting with symptoms. This...
August 11 2020
-
Crohn's disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract, in which the pathogenesis is believed to be partly influenced by the gut microbiome. Probiotics can be used to manipulate the microbiome and have therefore been considered as a potential therapy for CD. There is some evidence that probiotics benefit other...
July 17 2020
-
Gastric cancer is the third most common cause of cancer death worldwide. Individuals infected with Helicobacter pylori have a higher likelihood of developing gastric cancer than individuals who are not infected. Eradication of H. pylori in healthy asymptomatic individuals in the general population may reduce the incidence of...
July 6 2020
-
Oral 5‐aminosalicylic acid (5‐ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. It was previously found that 5‐ASA drugs in doses of at least 2 g/day were more effective than placebo but no more effective than SASP for inducing remission in ulcerative colitis (UC).Read...
July 4 2020
-
Welcome to the new Cochrane Gut website! Here you will be able to discover what we do, details of how to author a systematic review with our group and how to access Cochrane publications. This site aims to promote discussion and interaction between the editorial team and anyone who has an interest in working with us. We look forward to...
July 4 2020
-
The UGPD group will be holding a standard author training workshop in Hamilton from July 4th through 6th, 2014. This three day workshop is open to Cochrane and non-Cochrane review authors. Registration is limited to 20 participants and is already over half subsribed. Further information on registration is available.
May 12 2014
-
Introduction to writing a Cochrane Review - Hamilton, CanadaIntroduction to writing a Cochrane systematic review (Standard Author Training)McMaster University, Hamilton4-6 July 2014This three-day workshop is designed for new authors starting a Cochrane systematic review. A mixture of presentations and hands-on sessions will give you an...
April 8 2014
-
The Cochrane Methodological Expectations of Cochrane Intervention Reviews (MECIR) conduct and reporting standards are now available.Cochrane Reviews are seen as exemplifying best practice in the quality of both their conduct and reporting. To maintain this position we need to improve and maintain the quality of our output...
October 2 2012
-
The top ten most accessed reviews from Upper Gastrointestinal and Pancreatic Diseases Group in 2011 are:Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents Enteral versus parenteral nutrition for acute pancreatitisAntibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute...
September 24 2012
Medications used to treat inflammatory bowel disease (IBD) have significantly improved patient outcomes and delayed time to surgery. However, some of these therapies are recognized to increase the general risk of infection and have an unclear impact on postoperative infection risk.Read the full review here.October 27 2020
About half of patients with Crohn's disease (CD) require surgery within 10 years of diagnosis. Resection of the affected segment is highly effective, however the majority of patients experience clinical recurrence after surgery. Most of these patients have asymptomatic endoscopic recurrence weeks or months before starting with symptoms. This...August 11 2020
Crohn's disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract, in which the pathogenesis is believed to be partly influenced by the gut microbiome. Probiotics can be used to manipulate the microbiome and have therefore been considered as a potential therapy for CD. There is some evidence that probiotics benefit other...July 17 2020
Gastric cancer is the third most common cause of cancer death worldwide. Individuals infected with Helicobacter pylori have a higher likelihood of developing gastric cancer than individuals who are not infected. Eradication of H. pylori in healthy asymptomatic individuals in the general population may reduce the incidence of...July 6 2020
Oral 5‐aminosalicylic acid (5‐ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. It was previously found that 5‐ASA drugs in doses of at least 2 g/day were more effective than placebo but no more effective than SASP for inducing remission in ulcerative colitis (UC).Read...July 4 2020
Welcome to the new Cochrane Gut website! Here you will be able to discover what we do, details of how to author a systematic review with our group and how to access Cochrane publications. This site aims to promote discussion and interaction between the editorial team and anyone who has an interest in working with us. We look forward to...July 4 2020